ANTAI GROUP(SH:600408) Xin Lang Cai Jing·2025-12-30 08:33Market Overview - On December 30, the Shanghai Composite Index closed flat, while the Shenzhen Component Index rose by 0.49% and the ChiNext Index increased by 0.63%. The North Stock 50 Index fell by 0.4%. The total trading volume in the Shanghai and Shenzhen markets reached 21,612 billion yuan, an increase of 36 billion yuan compared to the previous day [1]. Shanxi Sector Performance - The Shanxi sector experienced a decline of 1% on December 30, underperforming the Shanghai Composite Index, with a trading volume of 8.199 billion yuan, indicating insufficient market activity in the region [2]. - Among the 41 stocks in the Shanxi sector, only 4 stocks rose, while 36 stocks fell, and 1 stock remained flat, with the rising stocks accounting for less than 10% of the total [2]. - The stocks that increased had gains of less than 5%, with Qianyuan Pharmaceutical rising by 2.16%, Keda Control rising by 1.43%, Guangyuyuan rising by 0.61%, and Yongdong Co. rising by 0.14% [2]. - The leading decliner was Jinbo Biological, which fell by 6.06%. Additionally, Kexin Development, Huayang New Materials, Huhua Co., and Kuaijingtong all dropped by over 2%. Fourteen stocks, including Huayang Co., Antai Group, and Luhua Technology, fell by over 1%, while 17 stocks, including Shanxi Expressway, Jinkong Coal Industry, and Tongbao Energy, had declines of less than 1% [2]. - Notably, Antai Group saw its stock price double from 2.26 yuan per share on September 30 to 6.89 yuan per share on November 17. However, it has since experienced a decline for six consecutive trading days, with a cumulative drop of 12.91%. Investors should monitor company dynamics and relevant industry policies for future trends [2].